Objectives: The evolution of rifampicin resistance in Mycobacterium tuberculosis is a major threat to effective tuberculosis therapy. Much is known about the initial emergence of rifampicin resistance, but the further evolution of these resistant strains has only lately been subject to investigation. Although resistance can be caused by many different mutations in rpoB, among clinical M. tuberculosis isolates the mutation rpoB S531L is overwhelmingly the most frequently found. Clinical isolates with rpoB S531L frequently carry additional mutations in genes for RNA polymerase subunits, and it has been speculated that these are fitness-compensatory mutations, ameliorating the fitness cost of the primary resistance mutation. We tested this hypothesis using Salmonella as a model organism.
Introduction
The antibiotic rifampicin is an essential part of short-course antituberculosis treatment. 1 Rifampicin targets the b-subunit of the RNA polymerase (RNAP), where it inhibits RNA transcription shortly after initiation. 2 Studies of in vitro-selected rifampicinresistant mutants, 3 -5 supported by analysis of clinical isolates of Mycobacterium tuberculosis, 6 show that rifampicin resistance (Rif R ) is nearly always caused by mutations affecting a small part of the b-subunit close to the catalytic centre of RNAP. 2, 7, 8 The Rif R mutation most frequently found in clinical isolates of M. tuberculosis is rpoB S531L. In M. tuberculosis from countries around the world, rpoB S531L was identified in 40% -93% of all Rif R isolates. 9 -13 One explanation for this high frequency might be low fitness cost. Characterization of paired strains carrying rpoB S531L showed that clinical isolates had lower fitness costs compared with laboratory-constructed strains, 14 suggesting that fitness-compensatory mutations had been acquired in clinical isolates in the time between developing Rif R and the taking of the clinical sample. 14 Model organisms, such as Escherichia coli and Salmonella enterica, are frequently used to study antibiotic resistance fitness costs and the genetics of fitness-compensatory evolution. 15 We have previously used Salmonella enterica serovar Typhimurium as a model organism to study compensatory evolution using the highcost Rif R mutation rpoB R529C as a starting point. 16 We showed that compensatory mutations were selected in the genes rpoA, rpoB and rpoC, which encode the a, b and b ′ subunits, respectively, of RNAP. 16 Studies on M. tuberculosis revealed that mutations in rpoA, rpoB and rpoC are also common among clinical isolates with the rpoB S531L mutation, 17, 18 and that secondary mutations might play a role in facilitating transmission of tuberculosis. 19 Previous genetic studies in E. coli or S. enterica have not included rpoB S531L, the most frequently found rpoB mutation in Rif R M. tuberculosis. Therefore, it has not been demonstrated experimentally that the secondary mutations found in M. tuberculosis isolates carrying rpoB S531L are compensatory mutations. Furthermore, studies on compensation in Rif R tuberculosis isolates have focused on the part of rpoC encoding the a-b ′ subunit interaction surface, 17, 19 whereas compensatory mutations for the Rif R mutation rpoB R529C are also found in other parts of the rpoC gene. 16 Because we have previously studied Rif R fitness cost and compensatory evolution in Salmonella, 16 we constructed an S. enterica strain with the Rif R mutation rpoB S531L and evolved it with selection for increased relative fitness. This mutation is infrequent in S. enterica, probably because the serine to leucine codon change requires two nucleotide substitutions in S. enterica (TCC to TTG), whereas in M. tuberculosis only one nucleotide substitution is required (TCG to TTG). Our aims were: (i) to identify and test putative fitness-compensatory mutations in the genes rpoA, rpoB and rpoC; and (ii) to identify hotspots for compensatory mutations in these genes to help determine whether the secondary mutations in M. tuberculosis are likely to be compensatory mutations.
Materials and methods

Bacterial strains and growth conditions
Bacterial strains are listed in Table S1 (available as Supplementary data at JAC Online). S. enterica serovar Typhimurium 14028s 20 was used in evolution and fitness experiments. The rpoB S531L mutation was made by oligonucleotide recombineering 21 (Table S2 , available as Supplementary data at JAC Online). Genetic markers were moved between strains by P22 transduction. 16 Bacteria were grown at 378C in Luria broth (LB) or on solid LA medium (LB solidified with 1.5% Oxoid agar) with 0.2% glucose and 3 mM CaCl 2 . Rifampicin was added as required at 100 mg/L. Growth rates were measured using a Bioscreen C machine (Oy Growth Curves Ab Ltd). 16 Rifampicin MIC values were determined using broth dilution. 16 Evolution by serial passage Independent lineages of TH8380 were grown in 15 mL tubes with shaking at 378C overnight in LB and LB+rifampicin, and serially passaged after each cycle of growth by transferring 2 mL of culture into 2 mL of fresh medium to initiate the next cycle. Each lineage was evolved for 28 cycles (280 generations), after which dilutions were plated on LA and incubated overnight at 378C. Two colonies per lineage of larger size than the ancestral strain were picked for analysis.
PCR amplification and DNA sequencing
Preparation of DNA was performed as previously described. 16 Primers for amplification and sequencing of rpoA, rpoB and rpoC are described in Table S3 (available as Supplementary data at JAC Online). DNA sequencing was carried out at Macrogen (Seoul, Korea) using purified PCR product.
Results
Characterization of rpoB S531L
The constructed strain harbouring rpoB S531L (TH8380), an infrequent mutation in S. enterica, showed Rif R (MIC: wild-type 12 mg/L; mutant 3000 mg/L) and a fitness cost of the mutation in LB of about 27% (LB generation time: wild-type 19.55 min; mutant 26.84 min).
Selection of compensatory mutations
Twenty independent lineages of TH8380 (rpoB S531L) were evolved by serial passage in rich medium (10 in LB and 10 in LB + rifampicin). After 280 generations, diluted cultures were plated on LA agar. Two colonies of larger size than the ancestral strain were isolated from each of the 20 lineages. The genes rpoA, rpoB and rpoC were sequenced for each of these 40 strains. The initial rpoB S531L mutation was still present in each of the 40 isolates. A secondary mutation in one of the three sequenced genes was carried by 45% (9 of 20) of the isolates evolved in LB and 95% (19 of 20) of the isolates evolved in LB + rifampicin. In total, 18 different putative compensatory mutations were identified ( Table 1 ).
The secondary mutations are necessary and sufficient for growth compensation
The growth rates of the strains containing each one of the secondary mutations in the RNAP genes were determined, and all showed an increase compared with the ancestral Rif R strain (Table 1) . Isogenic strains were constructed, and the growth rates of the reconstructed mutant strains were indistinguishable from the growth rates of the respective parental strains (Table S4 , available as Supplementary data at JAC Online), showing that the individual secondary mutations found in rpoA, rpoB and rpoC are sufficient to generate the growth-compensated phenotypes. In 12 of the 40 evolved strains no secondary mutation was found in the three RNAP genes, although they grew faster than the ancestral strain (Table S5 , available as Supplementary data at JAC Online), confirming that compensatory evolution had taken place. Since the focus of this study was on the overlap of compensatory mutations within the rpoA, rpoB and rpoC genes with secondary mutations found in clinical isolates, these strains were excluded from further analysis.
Compensatory mutations overlap with secondary mutations identified in RNAP genes in clinical isolates
Two recent studies based on genome sequencing of M. tuberculosis isolates identified a set of mutations in RNAP genes as putative compensatory mutations for the Rif R mutation rpoB S531L. 17, 18 Together with the 18 compensatory mutations found in this study, a total of 55 secondary mutations associated with rpoB S531L have been identified in rpoA (n¼ 9), rpoB (n¼ 10) and rpoC (n¼ 36). The 37 different secondary mutations identified in M. tuberculosis carrying rpoB S531L are clustered at a few locations within the primary sequences of rpoA (codons 189 -199), rpoB (codons 516 -561 and 848) and rpoC (codons 257, 358 -452 and 606-674) (Figure 1 ). Compensatory mutations identified in this study map within, or very close to, clusters carrying 36 of the 37 M. tuberculosis secondary mutations. Thus, there is a very good overlap between the locations of secondary mutations identified in clinical isolates of M. tuberculosis 17, 18 and the locations of fitness-compensatory mutations selected in this study. In addition, we selected several novel compensatory mutations at Brandis and Hughes other locations within rpoB and rpoC (Figure 1 ). These additional mutations could be specific for S. enterica or, alternatively, could be mutations not yet found in M. tuberculosis (see the Discussion section).
Discussion
We evolved a rifampicin-resistant S. enterica strain carrying the Rif R mutation rpoB S531L (the most frequently found rpoB mutation in Rif R M. tuberculosis), with selection for increased growth fitness. We identified 18 different secondary mutations within the genes rpoA, rpoB and rpoC. Genetic reconstructions showed that each of these secondary mutations is individually sufficient to ameliorate the fitness cost caused by the rpoB S531L Rif R mutation. In the absence of rifampicin, some strains evolved increased relative fitness without acquiring a secondary mutation within the three RNAP genes. However, strains that were compensated by secondary mutations in rpoA, rpoB or rpoC benefited from a greater increase in growth rate in the presence of rifampicin than strains that acquired compensatory mutations in other loci ( Figure S1 , available as Supplementary data at JAC Online), plausibly explaining their overwhelming predominance under those selective conditions. This suggests that there may be a close connection between exposure to rifampicin and selection of compensatory mutations affecting the RNAP genes.
Finally, we compared the locations of compensatory mutations selected in this study with the locations of secondary mutations identified in clinical isolates of M. tuberculosis carrying rpoB S531L. 17, 18 All of the secondary mutations within rpoA cluster in a section of the protein 11 amino acids long, where we also identified compensatory mutations (Figure 1) . Only a few secondary mutations were identified in rpoB, of which three are known to be Rif R mutations (D516V, D516Y, S522L) and we confirmed compensatory mutations at these and other locations within rpoB (Figure 1 ). Within rpoC, most secondary mutations are found in two separate regions, and compensatory mutations were also selected in this study in each of these regions of the gene. The majority (26 of 37) of the RNAP secondary mutations identified in clinical isolates are found in two clusters (Figure 1 ), in regions of rpoA and rpoC, which encode the a-b ′ interaction region of RNAP. However, because most (21 of 25) of the secondary mutations in rpoC were found in a study that sequenced only the a-b ′ interaction region, it cannot be excluded that some clinical isolates carried secondary mutations in other parts of the rpoC gene. 17 In conclusion, our findings genetically support the empirical data that secondary mutations within the genes rpoA, rpoB and rpoC, found in clinical M. tuberculosis isolates, do indeed compensate for the growth defect caused by the Rif R mutation rpoB S531L. Furthermore, we have identified several distinct regions in the genes rpoA, rpoB, and rpoC that are potentially important Number of independent isolates (from independent lineages) of each mutant. c Growth medium in which growth-compensatory mutants were selected.
Compensatory evolution of rpoB S531L 2495   JAC T196P  V192A  T196A  V192G  R191L   A189E  D199G   D340Y  N339H  S522L   Q448E  V408G  A446D  I416V  Q448K  I442L   L452V  A446V   N606H  N606K  N606S  T674I   D622E  R943H  I937T  S942L   R1075C  R1075L  G1136A   H450N   G444D  G358S  G257R   Y360H  P359A   P359R  L374V  F377S   E546K  G809A  E848D regions in the compensatory evolution of rpoB S531L, the most frequently found rpoB mutation in Rif R M. tuberculosis.
